Recall Record

Mason, OH, United States

AtriCure, Inc. recalls

3 recalls recorded since 2018, most recently on 28 November 2023. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)1
Terminated or completed2
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
28 November 2023
Reason
AtriCure has identified certain lots of tank hose assemblies where a second-tier supplier provided incorrect tank hose assemblies. These tank hose assemblies were provided with an outer sheathing that does not have required pin perforations and the inner tube of the hose is not the correct material.
Distribution
US Nationwide. Brazil, Canada, Japan, Taiwan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0927-2024, Z-0928-2024

Terminated Class II Medical devices

Recall started
29 May 2019
Terminated
4 May 2020
Reason
The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
Distribution
Worldwide distribution - US Nationwide distribution, and countries of Germany and Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-1887-2019

Terminated Class II Medical devices

Recall started
22 January 2019
Terminated
12 May 2020
Reason
There is a potential for patients undergoing ablation to experience an elevated risk for TE; during stand-alone off-pump procedures where cardio pulmonary bypass (CPB) was not utilized.
Distribution
AL, AR, AZ, CA, CT, CO, FL, ID, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA & WI Internationally - Germany, Italy, Netherlands, France, Austria, United Kingdom, Poland, Czech Republic, United Arab Emirates, Sweden, Switzerland, Ku
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0832-2019, Z-0831-2019, Z-0830-2019, Z-0829-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.